Vivo Capital Closes Oversubscribed $635M Life Sciences Fund
September 12, 2018 — 12:50 CST
This Data Is Locked!
This area is available only to Subscribers.
Healthcare investment firm Vivo Capital has announced the final closing of its life science fund, Vivo Opportunity Fund, at an oversubscribed US$635 million, bringing the... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals